The association between smoking and breast cancer characteristics and outcome by Goldvaser, Hadar, Gal, Omer, Rizel, Shulamith, Hendler, Daniel, Neiman, Victoria, Shochat, Tzippy, Sulkes, Aaron, Brenner, Baruch, Yerushalmi, Rinat

Get full text

First-line programmed death-1 inhibitor treatment for locoregionally advanced or metastatic cutaneous squamous cell carcinoma - A real-world experience from Israel by Averbuch, Itamar, Salman, Saeed, Shtamper, Noa, Doweck, Ilana, Popovtzer, Aron, Markel, Gal, Hendler, Daniel, Finkel, Inbar, Moore, Assaf, Fenig, Eyal, Taha, Tarek, Mhameed, Kamel, Kurman, Noga, Billan, Salem

Get full text

Adjuvant Docetaxel and Cyclophosphamide (DC) with prophylactic granulocyte colony-stimulating factor (G-CSF) on days 8 &12 in breast cancer patients: a retrospective analysis by Yerushalmi, Rinat, Goldvaser, Hadar, Sulkes, Aaron, Ben-Aharon, Irit, Hendler, Daniel, Neiman, Victoria, Ciuraru, Noa Beatrice, Bonilla, Luisa, Amit, Limor, Zer, Alona, Granot, Tal, Rizel, Shulamith, Stemmer, Salomon M

Get full text

The Association between Treatment for Metabolic Disorders and Breast Cancer Characteristics by Yerushalmi, Rinat, Brenner, Baruch, Shochat, Tzippy, Shepshelovich, Daniel, Neiman, Victoria, Hendler, Daniel, Rizel, Shulamith, Goldvaser, Hadar, Sulkes, Aaron

Get full text

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controll... by Blank, Christian U, Mandalà, Mario, Long, Georgina V, Atkinson, Victoria G, Dalle, Stéphane, Haydon, Andrew M, Meshcheryakov, Andrey, Carlino, Matteo S, Sandhu, Shahneen, Larkin, James, Puig, Susana, Ascierto, Paolo A, Koornstra, Rutger, Hernandez-Aya, Leonel, Di Giacomo, Anna Maria, Grob, Jean-Jacques, Gutzmer, Ralf, Jamal, Rahima, Lorigan, Paul C, van Akkooi, Alexander C J, Krepler, Clemens, Ibrahim, Nageatte, Marreaud, Sandrine, Kicinski, Michal, Suciu, Stefan, Robert, Caroline, Menzies, Alex, Lesimple, Thierry, Maio, Michele, Brown, Michael, Hersey, Peter, Schachter, Jacob, Barrow, Catherine, Song, Xinni, Dutriaux, Caroline, Quaglino, Pietro, Meier, Friedegund, Stroyakovskiy, Daniil, Bastholt, Lars, Guillot, Bernard, Garbe, Claus, Ortiz Romero, Pablo Luis, Grange, Florent, Mohr, Peter, Algazi, Alain, Bechter, Oliver, Hernberg, Micaela, Arnault, Jean-Philippe, Loquai, Carmen, Meiss, Frank, Simon, Jan-Christoph, Bar-Sela, Gil, Chiarion Sileni, Vanna, Fitzharris, Bernard, McCrystal, Mike, Parente, Phillip, Baurain, Jean-Francois, Hauschild, Axel, Yamazaki, Naoya, Dummer, Reinhard, Walker, John, Geoffrois, Lionel, Leccia, Marie-Thérèse, Kretschmer, Lutz, Hendler, Daniel, Lotem, Michal, Mackiewicz, Andrzej, Sekulovic, Lidija, Dunwoodie, Elaine, Hoeller, Christoph, Machet, Laurent, Corrie, Philippa, Schmidt, Henrik, Descamps, Vincent, Kiecker, Felix, Ferrucci, Pier Francesco, Aarts, Maureen, Jameson, Michael, Ferreira, Paula, Kim, Kevin, Hofmann-Wellenhof, Reiner, Aubin, François, Utikal, Jochen, Ferraresi, Virginia, Inozume, Takashi, Kiyohara, Yoshio, Groenewegen, Gerard, Kapiteijn, Helena, Casasola, Richard, Crook, Timothy, Marshall, Ernest, Skytta, Tanja, Avril, Marie-Francoise, Jouary, Thomas, Hein, Rüdiger, Terheyden, Patrick, Straume, Oddbjorn, Martins, César, Mukhametshina, Guzel, Nathan, Paul

Get full text

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled... by Bottomley, Andrew, Blank, Christian U, Mandalà, Mario, Long, Georgina V, Atkinson, Victoria G, Khattak, Adnan, Carlino, Matteo S, Sandhu, Shahneen, Puig, Susana, Larkin, James, Lorigan, Paul C, Rutkowski, Piotr, Schadendorf, Dirk, Koornstra, Rutger, Hernandez-Aya, Leonel, Di Giacomo, Anna Maria, van den Eertwegh, Alfonsus J M, Grob, Jean-Jacques, Gutzmer, Ralf, Jamal, Rahima, Krepler, Clemens, Marreaud, Sandrine, Kicinski, Michal, Robert, Caroline, Lesimple, Thierry, Maio, Michele, Linette, Gerald, Mortier, Laurent, Svane, Inge Marie, Schachter, Jacob, Brown, Michael, Hersey, Peter, Barrow, Catherine, Kudchadkar, Ragini, Song, Xinni, Quaglino, Pietro, Queirolo, Paola, Stroyakovskiy, Daniil, Romero, Pablo Luis Ortiz, Bastholt, Lars, Garbe, Claus, Grange, Florent, Mohr, Peter, Bechter, Oliver, Loquai, Carmen, Meiss, Frank, Bar-Sela, Gil, Fitzharris, Bernard, Saiag, Philippe, Arnault, Jean-Philippe, Baurain, Jean-Francois, Combemale, Patrick, Dummer, Reinhard, Hauschild, Axel, Yamazaki, Naoya, Milhem, Mohammed, Kretschmer, Lutz, Dunwoodie, Elaine, Walker, John, Hendler, Daniel, Dzienis, Marcin, Hospers, Geke A.P., Hassel, Jessica, Passos, Maria-Jose, Levin, Max, Hoeller, Christoph, Machet, Laurent, Hallmeyer, Sigrun, Waterston, Ashita, Descamps, Vincent, Kiecker, Felix, Aarts, Maureen, Schmidt, Henrik, Raimundo, Ana, Lacour, Jean-Philippe, Berking, Carola, Ferrucci, Pier Francesco, Jameson, Michael, Kim, Kevin, Yokota, Kenji, Aubin, François, Kapiteijn, Helena, Boehncke, Wolf-Henning, Utikal, Jochen, Casasola, Richard, Marshall, Ernest, Richtig, Erika, Matkovic, Suzana, Crook, Timothy, Kiyohara, Yoshio, Avril, Marie-Francoise, Hein, Rüdiger, Nathan, Paul, Aoi, Jun, Skytta, Tanja, Jouary, Thomas, Takenouchi, Tatsuya, Straume, Oddbjorn, Martins, César, Mukhametshina, Guzel

Get full text

Tilsotolimod Exploits the TLR9 Pathway to Promote Antigen Presentation and Type 1 IFN Signaling in Solid Tumors: A Multicenter International Phase I/II Trial (ILLUMINATE-101) by Babiker, Hani, Borazanci, Erkut, Subbiah, Vivek, Agarwala, Sanjiv, Algazi, Alain, Schachter, Jacob, Lotem, Michael, Maurice-Dror, Corinne, Hendler, Daniel, Rahimian, Shah, Minderman, Hans, Haymaker, Cara, Mahadevan, Daruka, Bernatchez, Chantale, Murthy, Ravi, Hultsch, Rolf, Kaplan, Nadia, Woodhead, Gregory, Hennemeyer, Charles, Chunduru, Srinivas, Anderson, Peter M, Diab, Adi, Puzanov, Igor

Get full text

Abstract P1-18-33: Taxane versus vinorelbine in combination with pertuzumab and trastuzumab for first-line treatment of patients with metastatic HER2-positive breast cancer - A ret... by Reinhorn, Daniel Jack, Kuchuk, Irina, Prus, Judit, Sarfaty, Michal, Goldvaser, Hadar, Rotem, Ofer, Hendler, Daniel, Zoref, Dalia, Neiman, Victoria, Shohat, Tzipora, Ulitsky, Olga, Yust-Katz, Shlomit, Nisenbaum, Bella, Gottfried, Maya, Yerushalmi, Rinat

Get full text

Taxane versus vinorelbine in combination with trastuzumab and pertuzumab for first-line treatment of metastatic HER2-positive breast cancer: a retrospective two-center study by Reinhorn, Daniel, Kuchuk, Iryna, Shochat, Tzippy, Nisenbaum, Bella, Sulkes, Aaron, Hendler, Daniel, Rotem, Ofer, Tsoref, Daliah, Olitzky, Olga, Goldvaser, Hadar, Sarfaty, Michal, Neiman, Victoria, Prus, Judit, Gottfried, Maya, Yust-Katz, Shlomit, Yerushalmi, Rinat

Get full text

Abstract P3-08-41: Central nervous system metastases in breast cancer: The impact of age on patterns of development and outcome by Berliner, Matan Ben-Zion, Yust-Katz, Shlomit, Lavie, Inbar, Amiel, Alexandra, Zoref, Dalia, Hendler, Daniel, Goldvaser, Hadar, Sarfaty, Michal, Rotem, Ofer, Ulitsky, Olga, Siegal, Tali, Neiman, Victoria, Yerushalmi, Rinat

Get full text

Central nervous system metastases in breast cancer: the impact of age on patterns of development and outcome by Ben-Zion Berliner, Matan, Yerushalmi, Rinat, Lavie‏, Inbar, Benouaich-Amiel, Alexandra, Tsoref, Daliah, Hendler, Daniel, Goldvaser, Hadar, Sarfaty, Michal, Rotem, Ofer, Ulitsky, Olga, Siegal, Tali, Neiman, Victoria, Yust-Katz, Shlomit

Get full text

Abstract CT134: Tilsotolimod engages the TLR9 pathway to promote antigen presentation and Type-I IFN signaling in solid tumors by Babiker, Hani M., Subbiah, Vivek, Ali, Asim, Algazi, Alain, Schachter, Jacob, Lotem, Michal, Maurice-Dror, Corinne, Hendler, Daniel, Rahimian, Shah, Minderman, Hans, Haymaker, Cara, Bernatchez, Chantale, Murthy, Ravi, Hultsch, Rolf, Caplan, Nadia, Woodhead, Gregory, Hennemeyer, Charles, Chunduru, Sri, Anderson, Peter, Diab, Adi, Borazanci, Erkut, Puzanov, Igor

Get full text

Prospective Long-Term Follow-Up of Pulmonary Diffusion Capacity Reduction Caused by Dose-Dense Chemotherapy in Patients with Breast Cancer by Yerushalmi, Rinat, Gelmon, Karen, Hendler, Daniel, Granot, Tal, Neiman, Victoria, Sulkes, Aaron, Stemmer, Salomon Marcello, Landman, Yosef, Kramer, Mordechai Reuven

Get full text

Widespread morbilliform rash due to sorafenib or vemurafenib treatment for advanced cancer; experience of a tertiary dermato-oncology clinic by Ollech, Ayelet, Stemmer, Salomon M., Merims, Sharon, Lotem, Michal, Popovtzer, Aron, Hendler, Daniel, Hodak, Emmilia, Didkovsky, Elena, Amitay-Laish, Iris

Get full text

Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial by Maio, Michele, Lewis, Karl, Demidov, Lev, Bondarenko, Igor, Ascierto, Paolo A, Herbert, Christopher, Mackiewicz, Andrzej, Guminski, Alexander, Goodman, Grant R, Simmons, Brian, Ye, Chenglin, Cinat, Gabriela, Brown, Michael, Guminski, Alexander, Haydon, Andrew, Khattak, Adnan, McNeil, Catriona, Power, Jeremy, Roberts-Thomson, Rachel, Underhill, Craig, Berger, Thomas, Awada, Ahmad, Blockx, Nathalie, Buyse, Veronique, Mebis, Jeroen, Franke, Fábio André, Jobim de Azevedo, Sérgio, Silva Lazaretti, Nicolas, Mihalcioiu, Catalin, Petrella, Teresa, Song, Xinni, Wong, Ralph, Dabelic, Nina, Plestina, Stjepko, Vojnovic, Zeljko, Kocak, Ivo, Krajsova, Ivana, Kubala, Eugen, Melichar, Bohuslav, Dutriaux, Caroline, Joly, Pascal, Lacour, Jean-Philippe, Meyer, Nicolas, Mortier, Laurent, Fluck, Michael, Hassel, Jessica, Hauschild, Axel, Donnellan, Paul, McCaffrey, John, Power, Derek, Ariad, Samuel, Bar-Sela, Gil, Ron, Ilan, Schachter, Jacob, Berruti, Alfredo, Bianchi, Luca, Chiarion Sileni, Vanna, Cognetti, Francesco, Danielli, Riccardo, Di Giacomo, Anna Maria, Gianni, Luca, Goldhirsch, Aron, Guida, Michele, Maio, Michele, Mandalà, Mario, Marchetti, Paolo, Santoro, Armando, Kapiteijn, Ellen, Mackiewicz, Andrzej, Rutkowski, Piotr, Ferreira, Paula, Demidov, Lev, Gafton, Georgy, Makarova, Yulia, Jovanovic, Darjana, Kandolf Sekulovic, Lidija, Curiel Garcia, Maria Teresa, Majem Tarruella, Margarita, Marquez Rodas, Ivan, Puliats Rodriguez, Jose-M, Papworth, Karin, Bondarenko, Igor, Corrie, Pippa, Harries, Mark, Herbert, Christopher, Middleton, Mark, Patel, Poulam, Talbot, Toby, Agarwala, Sanjiv, Chapman, Paul, Conry, Robert, Doolittle, Gary, Gangadhar, Tara, Hallmeyer, Sigrun, Kass, Frederic, Lewis, Karl, Salama, April, Sikic, Branimir, Spigel, David, Whitman, Eric

Get full text

Adjuvant vemurafenib in resected, BRAF V600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial by Maio, Michele, Lewis, Karl, Demidov, Lev, Mandalà, Mario, Bondarenko, Igor, Ascierto, Paolo A, Herbert, Christopher, Mackiewicz, Andrzej, Rutkowski, Piotr, Guminski, Alexander, Goodman, Grant R, Simmons, Brian, Ye, Chenglin, Yan, Yibing, Schadendorf, Dirk

Get full text

Adjuvant Docetaxel and Cyclophosphamide by Yerushalmi, Rinat, Goldvaser, Hadar, Sulkes, Aaron, Ben-Aharon, Irit, Hendler, Daniel, Neiman, Victoria, Ciuraru, Noa Beatrice, Bonilla, Luisa, Amit, Limor, Zer, Alona, Granot, Tal, Rizel, Shulamith, Stemmer, Salomon M

Get full text

Adjuvant Docetaxel and Cyclophosphamide on Days 8 12 in Breast Cancer Patients: A Retrospective Analysis by Yerushalmi, Rinat, Goldvaser, Hadar, Sulkes, Aaron, Ben-Aharon, Irit, Hendler, Daniel, Neiman, Victoria, Ciuraru, Noa Beatrice, Bonilla, Luisa, Amit, Limor, Zer, Alona, Granot, Tal, Rizel, Shulamith, Stemmer, Salomon M

Get full text

Adjuvant Docetaxel and Cyclophosphamide (DC) with Prophylactic Granulocyte Colony-Stimulating Factor (G-CSF) on Days 8 &12 in Breast Cancer Patients: A Retrospective Analysis: e107... by Yerushalmi, Rinat, Goldvaser, Hadar, Sulkes, Aaron, Ben-Aharon, Irit, Hendler, Daniel, Neiman, Victoria, Ciuraru, Noa Beatrice, Bonilla, Luisa, Amit, Limor, Zer, Alona

Get full text

The Chinese “Human Flesh” Web： the first decade and beyond by Wang, Fei-Yue, Zeng, Daniel, Zhang, Qingpeng, Hendler, James A, Cao, Jianping

Get full text